SCOTT MORENSTEIN

Profile

First Name

: SCOTT

Middle Name

:

Last Name

: MORENSTEIN

Related Companies
Titles
Company Name
Related People
DIRECTOR
GEMIN X PHARMACEUTICALS INC
TIMOTHY J. BARBERICH, AARON DAVIDSON, D. MICHAEL DIXON, PETER R. DOLAN, ROBERT GORMAN, ANDREW R. JORDAN, ROBERT G. MCNEIL, ERIC W. ROBERTS, GORDON C. SHORE, JEAN VIALLET
DIRECTOR
VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.
JAY CECIL, A. RACHEL LEHENY, ERIC W. ROBERTS, N/A VALENCE LIFE SCIENCES GP II, LLC
DIRECTOR
CELATOR PHARMACEUTICALS INC
PATRICK BRADY, J. KEVIN BUCHI, KENNETH GALBRAITH, BRENDA D. GAVIN, BRENDA D GAVIN, D.V.M., SCOTT JACKSON, RICHARD S. KOLLENDER, LAWRENCE MAYER, LAWRENCE D MAYER, LAWRENCE D. MAYER, JOSEPH A. MOLLICA, JOSEPH A. MOLLIICA, PH.D., FRED M. POWELL, JACKSON T. SCOTT, NICOLE VITULLO, DAVID WOOD, ALEX ZISSON
DIRECTOR
VELICEPT THERAPEUTICS, INC.
JAMES BENNETHUM, CORY S. FREEDLAND, CORY FREEDMAN, DOUG GESSL, DOUGLAS GESSL, DAVID HIRSCH, DAVID HIRSCH, M.D., AIDAN KING, AIDAN KING, MBA, CFA, JILL BECKER MAST, STEPHEN TULLMAN, JAMES WALKER, JAMES C. WALKER
DIRECTOR
MOLECULAR TEMPLATES, INC.
JEFFREY W. BIRD, MICHAEL BROXSON, BRUCE C. COZADD, JOHN G. CURD, ADAM D. CUTLER, JOEL A. FERNANDES, GABRIELA GRUIA, WILLIAM A. HALTER, DAVID HIRSCH, DAVID HOFFMAN, DAVID HOFFMANN, DAVID R. HOFFMANN, WILFRED E. JAEGER, JASON KIM, JASON S. KIM, STEWART M. KROLL, KEVIN LALANDE, KEVIN M. LALANDE, JONATHAN LANFEAR, MARK D. MATTEUCCI, ERIC E. POMA, ERIC ROGERS, CORSEE SANDERS, HAROLD E. SELICK, DAVID VALACER, ROGER WALTZMAN, ROGER J. WALTZMAN
DIRECTOR
ANTIOS THERAPEUTICS INC.
TAMRA ADAMS, DAVID CANNER, HENRY LIN CHEN, ABEL DE LA ROSA, CRAIG GORDON, PATRICK HIGGINS, IDEAN MARVASTY, DOUGLAS MAYERS, GREGORY MAYES, IYONA RAJKOMAR, BENJAMIN ROVINSKI, NICOLE VITULIO, NICOLE VITULLO
DIRECTOR
PRIMMUNE THERAPEUTICS, INC.
JAMES R APPLEMAN, JAMES R. APPLEMAN, TODD J HARRIS, TODD J. HARRIS, CHARLES MCDERMOTT, AMIR NASHAT, PAULO S RANGEL, PAULO S. RANGEL, ANDREW RUBINSTEIN
DIRECTOR
PALVELLA THERAPEUTICS, INC.
ADITYA ASOKAN, MICHAEL CHRISTOPHER, TODD DAVIS, JOHN DOUX, CORY FREEDLAND, KATHLEEN GOIN, TIMOTHY HENKEL, ELAINE HERON, GEORGE JENKINS, WESLEY H. KAUPINEN, JEFFREY MARTINI, KATHLEEN MCGOWAN, KATHLEEN A. MCGOWAN, BRAHAM SHROOT, PH.D., DAVID TIERNEY, TADD S WESSEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-16 
2021-11-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-02 
2021-04-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
2020-11-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
2020-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2020-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
2020-03-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2018-07-27 
2020-03-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2019-02-04 
2020-03-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2020-02-28 
2019-12-03
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2019-11-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-18 
2019-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-11-05 
2018-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-20 
2018-07-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-12 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2017-08-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2017-04-20
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-12-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2013-05-13
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2012-08-28 
2013-03-14
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2012-03-30 
2010-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-07